Online Database of Chemicals from Around the World
| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 356561-08-5 | 5-Iodo-4-methyl-2-pyridinamine | C6H7IN2 |
| 356570-52-0 | 4-Methylbenzylboronic acid pinacol ester | C14H21BO2 |
| 356572-08-2 | 1-Hydroxy-3-amino-5,7-dimethyladamantane hydrochloride | C12H21NO.HCl |
| 356782-84-8 | 3,4-Dihydro-3-oxo-4-beta-D-ribofuranosyl-2-pyrazinecarboxamide | C10H13N3O6 |
| 356783-16-9 | 3,6-Dichloro-2-pyrazinecarbonitrile | C5HCl2N3 |
| 356783-28-3 | 3,6-Difluoro-2-pyrazinecarbonitrile | C5HF2N3 |
| 356783-31-8 | 6-Fluoro-3-oxo-3,4-dihydro-2-pyrazinecarbonitrile | C5H2FN3O |
| 356786-94-2 | Pantothenic acid-13C4,15N hemicalcium salt | 13C6C12H32Ca15N2O10 |
| 357154-27-9 | Ertapenem Ring Open Impurity | C22H27N3O8S |
| 357166-29-1 | Pemetrexed disodium hepthydrate | C20H19N5Na2O6.7(H2O) |
| 357166-30-4 | Pemetrexed disodium hydrate | 2(C20H19N5Na2O6).5(H2O) |
| 357172-63-5 | Morpholine [(5-methyl-1H-1,2,4-triazol-3-yl)thio]acetate | C5H7N3O2S.C4H9NO |
| 357189-94-7 | Posaconazole 3-OXO impurity | C37H40F2N8O5 |
| 357189-95-8 | Posaconazole Impurity B | C37H40F2N8O6 |
| 357209-32-6 | 2,6-Bis[(3aR,8aS)-(+)-8H-indeno[1,2-d]oxazolin-2-yl)pyridine | C25H19N3O2 |
| 357219-41-1 | 9,9-Bis(2-ethylhexyl)fluorene-2,7-bis(boronic acid pinacol ester) | C41H64B2O4 |
| 357263-13-9 | BMS 378806 | C22H22N4O4 |
| 357263-40-2 | 4-Methoxy-1H-pyrrolo[2,3-c]pyridine | C8H8N2O |
| 357263-41-3 | 7-Chloro-1H-pyrrolo[2,3-c]pyridine | C7H5ClN2 |
| 357263-42-4 | 7-Methyl-4-azaindole | C8H8N2 |
| 357263-43-5 | 5-Chloro-7-methyl-1H-pyrrolo[3,2-b]pyridine | C8H7ClN2 |
| 357263-48-0 | 7-Chloro-1H-pyrrolo[3,2-b]pyridine | C7H5ClN2 |
| 357263-49-1 | Methyl 7-azaindole-3-glyoxylate | C10H8N2O3 |
| 357274-85-2 | [1-(Trifluoromethyl)vinyl]boronic acid | C3H4BF3O2 |
| 357289-65-7 | 4-Cyanofuran-2-carboxylic acid methyl ester | C7H5NO3 |
| 357336-20-0 | Brivaracetam | C11H20N2O2 |
| 357336-99-3 | Brivaracetam (alfaR, 4S)-Isomer | C11H20N2O2 |
| 357337-00-9 | Brivaracetam (alfaR, 4R)-Isomer | C11H20N2O2 |
| 357338-13-7 | (alphaS)-alpha-Ethyl-2,5-dihydro-2-oxo-4-propyl-1H-pyrrole-1-acetamide | C11H18N2O2 |
| 357399-43-0 | 2-Hydroxy-2-(3-chlorophenyl)-3,5,5-trimethylmorpholine | C13H18ClNO2 |
| 357405-75-5 | 4-Bromo-2,5-difluorobenzaldehyde | C7H3BrF2O |
| 357426-12-1 | 3-(Aminomethyl)-2,3-dihydro-1H-indene-1-carboxylic acid methyl ester | C12H15NO2 |
| 357437-74-2 | 3,6-Dibromo-9-(4-methylphenyl)-9H-carbazole | C19H13Br2N |
| 357645-16-0 / 145918-59-8 | 6-Hydroxy-4-(4-hydroxy-3-methoxyphenyl)-3-hydroxymethyl-7-methoxy-3,4-dihydro-2-naphthaldehyde | C20H20O6 |
| 357645-37-5 | 2,7-Dibromo-9,9-bis(4-methylphenyl)-9H-fluorene | C27H20Br2 |
| 357645-40-0 | N2,N7-Di-1-naphthalenyl-N2,N7,9,9-tetraphenyl-9H-fluorene-2,7-diamine | C57H40N2 |
| 357927-50-5 | 2-Bromo-4-fluoropyridine | C5H3BrFN |
| 358374-59-1 | 4,4'-[1,4-phenylenedi-(1E)-2,1-ethenediyl]bis[N,N-diphenylbenzenamine] | C46H36N2 |
| 358629-47-7 | (alphaZ)-alpha-Ethylidene-2-oxo-1-pyrrolidineacetamide | C8H12N2O2 |
| 358629-51-3 | Levetiracetam Impurity 10 | C9H15NO3 |
| 358629-53-5 | Levetiracetam Impurity F | C10H17NO3 |
| 358672-65-8 | 5-Bromo-6-chloropyridin-2-amine | C5H4BrClN2 |
| 358721-33-2 | Apocynol A | C13H20O3 |
| 358731-27-8 | 2-Ethyl-d5-2-hydroxybutyric-3,3,4,4,4-d5 acid | C6H2D10O3 |
| 358748-29-5 | (4R,5S,6S)-5-(Acetyloxy)-4-(benzoyloxy)-6-[(benzoyloxy)methyl]-6-hydroxy-2-cyclohexen-1-one | C23H20O8 |
| 358780-13-9 | 6-(Trifluoromethyl)nicotinoyl chloride | C7H3ClF3NO |
| 358780-14-0 | 1-[6-(Trifluoromethyl)pyridin-3-yl]ethanone | C8H6F3NO |
| 358789-05-6 | 4-[[5-Bromo-4-(phenylamino)-2-pyrimidinyl]amino]benzoic acid | C17H13BrN4O2 |
| 358970-97-5 | Drinabant | C23H20Cl2F2N2O2S |
| 359004-04-9 | L-Valyl-L-isoleucyl-L-phenylalanyl-L-seryl-L-lysyl-L-alanyl-L-seryl-L-seryl-L-seryl-L-leucyl-L-glutaminyl-L-leucine | C58H98N14O18 |